An RNA platform successfully predicted fetal growth restriction within the second trimester of pregnancy, independent of ...

Pembrolizumab is under clinical development by Merck and currently in Phase I for Kaposi Sarcoma. According to GlobalData, Phase I drugs for Kaposi Sarcoma have an 84% phase transition success rate ...

Here, we describe the development of mature, expandable AT2 organoids derived from human fetal lungs which are phenotypically stable, can differentiate into AT1-like cells, and are genetically ...

In contrast, most previous studies have not examined fetal 3D measures during pregnancy and have only linked total weight gain across pregnancy, not just in the first trimester, with birthweight.

Using a novel three-dimensional organoid model that closely mimics the metastatic tumor environment ... patterns and enhancing diagnostic accuracy. Project: Fetal Monitoring Using a Wearable ...

The American Cancer Society's estimates for soft tissue sarcomas in the United States for 2025 are: About 13,520 new soft tissue sarcomas will be diagnosed (7,600 in males and 5920 in females). About ...

Methods: The clinical and ultrasound features of fibrous pseudotumor of the tunica ... (3) Rhabdomyosarcoma of the scrotal wall is a rare malignant tumor of the male reproductive system that may ...

After ultrasound irradiation (0.5 W/cm 2 ... In addition to analyzing the effects of various treatments in vitro, tumor suppression was assessed in Hepa1–6 tumor-bearing mice. The results shown in ...

To a large extent, your child’s treatment and prognosis (outlook) will depend on the stage, histology, and risk group of their Wilms tumor. Staging is based on the results of the physical exam and ...